APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antiemetics

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Antiemetics Market Outlook and Growth Opportunities 2026

2 January 2026190 pages

Choose your research edition.

Industry ResearchAntiemetics Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Antiemetics Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Antiemetics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antiemetics Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Antiemetics Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Antiemetics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Antiemetics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Antiemetics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antiemetics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Antiemetics market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Antiemetics market include Johnson & Johnson, Merck, Eli Lilly, Pfizer, GlaxoSmithKline, Baxter, Sanofi Aventis, Bristol Myers Squibb and Astellas, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Antiemetics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Antiemetics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Antiemetics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Antiemetics market size, projected growth trends, production technologies, key applications, and end-use industries.

Antiemetics Segment by Company

Johnson & Johnson

Merck

Eli Lilly

Pfizer

GlaxoSmithKline

Baxter

Sanofi Aventis

Bristol Myers Squibb

Astellas

Antiemetics Segment by Type

Steroids

Antihistamines (H1 histamine receptor antagonists)

Anticholinergics

Dopamine antagonists

Cannabinoids

Benzodiazepines

NK1 receptor antagonist

5-HT3 receptor antagonists

Others

Antiemetics Segment by Application

Retail Pharmacy

Online Pharmacy

Hospital Pharmacy

Others

Antiemetics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Antiemetics status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Antiemetics market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Antiemetics significant trends, drivers, influence factors in global and regions.

6. To analyze Antiemetics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antiemetics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antiemetics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antiemetics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Antiemetics market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Antiemetics industry.

Chapter 3: Detailed analysis of Antiemetics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Antiemetics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Antiemetics in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Antiemetics Industry Trends Table 2. Antiemetics Industry Drivers Table 3. Antiemetics Industry Opportunities and Challenges Table 4. Antiemetics Industry Restraints Table 5. Global Antiemetics Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Antiemetics Revenue Share by Company (2021-2026) Table 7. Global Antiemetics Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Antiemetics Sales Volume Share by Company (2021-2026) Table 9. Global Antiemetics Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Antiemetics Company Ranking, (2024-2026) & (USD Million) Table 11. Global Antiemetics Key Company Manufacturing Base & Headquarters Table 12. Global Antiemetics Company, Product Type & Application Table 13. Global Antiemetics Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Antiemetics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Steroids Table 18. Significant Companies of Antihistamines (H1 histamine receptor antagonists) Table 19. Significant Companies of Anticholinergics Table 20. Significant Companies of Dopamine antagonists Table 21. Significant Companies of Cannabinoids Table 22. Significant Companies of Benzodiazepines Table 23. Significant Companies of NK1 receptor antagonist Table 24. Significant Companies of 5-HT3 receptor antagonists Table 25. Significant Companies of Others Table 26. Global Antiemetics Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global Antiemetics Sales Volume by Type (2021-2026) & (K Units) Table 28. Global Antiemetics Sales Volume by Type (2027-2032) & (K Units) Table 29. Global Antiemetics Sales Volume Share by Type (2021-2026) Table 30. Global Antiemetics Sales Volume Share by Type (2027-2032) Table 31. Global Antiemetics Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Antiemetics Sales Value by Type (2021-2026) & (US$ Million) Table 33. Global Antiemetics Sales Value by Type (2027-2032) & (US$ Million) Table 34. Global Antiemetics Sales Value Share by Type (2021-2026) Table 35. Global Antiemetics Sales Value Share by Type (2027-2032) Table 36. Significant Companies of Retail Pharmacy Table 37. Significant Companies of Online Pharmacy Table 38. Significant Companies of Hospital Pharmacy Table 39. Significant Companies of Others Table 40. Global Antiemetics Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 41. Global Antiemetics Sales Volume by Application (2021-2026) & (K Units) Table 42. Global Antiemetics Sales Volume by Application (2027-2032) & (K Units) Table 43. Global Antiemetics Sales Volume Share by Application (2021-2026) Table 44. Global Antiemetics Sales Volume Share by Application (2027-2032) Table 45. Global Antiemetics Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Antiemetics Sales Value by Application (2021-2026) & (US$ Million) Table 47. Global Antiemetics Sales Value by Application (2027-2032) & (US$ Million) Table 48. Global Antiemetics Sales Value Share by Application (2021-2026) Table 49. Global Antiemetics Sales Value Share by Application (2027-2032) Table 50. Global Antiemetics Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 51. Global Antiemetics Sales by Region (2021-2026) & (K Units) Table 52. Global Antiemetics Sales Market Share by Region (2021-2026) Table 53. Global Antiemetics Sales by Region (2027-2032) & (K Units) Table 54. Global Antiemetics Sales Market Share by Region (2027-2032) Table 55. Global Antiemetics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Antiemetics Sales Value by Region (2021-2026) & (US$ Million) Table 57. Global Antiemetics Sales Value Share by Region (2021-2026) Table 58. Global Antiemetics Sales Value by Region (2027-2032) & (US$ Million) Table 59. Global Antiemetics Sales Value Share by Region (2027-2032) Table 60. Global Antiemetics Market Average Price (US$/Unit) by Region (2021-2026) Table 61. Global Antiemetics Market Average Price (US$/Unit) by Region (2027-2032) Table 62. Global Antiemetics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 63. Global Antiemetics Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Antiemetics Sales by Country (2021-2026) & (K Units) Table 65. Global Antiemetics Sales Market Share by Country (2021-2026) Table 66. Global Antiemetics Sales by Country (2027-2032) & (K Units) Table 67. Global Antiemetics Sales Market Share by Country (2027-2032) Table 68. Global Antiemetics Sales Value by Country (2021-2026) & (US$ Million) Table 69. Global Antiemetics Sales Value Market Share by Country (2021-2026) Table 70. Global Antiemetics Sales Value by Country (2027-2032) & (US$ Million) Table 71. Global Antiemetics Sales Value Market Share by Country (2027-2032) Table 72. Johnson & Johnson Company Information Table 73. Johnson & Johnson Business Overview Table 74. Johnson & Johnson Antiemetics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Johnson & Johnson Antiemetics Product Portfolio Table 76. Johnson & Johnson Recent Development Table 77. Merck Company Information Table 78. Merck Business Overview Table 79. Merck Antiemetics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Merck Antiemetics Product Portfolio Table 81. Merck Recent Development Table 82. Eli Lilly Company Information Table 83. Eli Lilly Business Overview Table 84. Eli Lilly Antiemetics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Eli Lilly Antiemetics Product Portfolio Table 86. Eli Lilly Recent Development Table 87. Pfizer Company Information Table 88. Pfizer Business Overview Table 89. Pfizer Antiemetics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Pfizer Antiemetics Product Portfolio Table 91. Pfizer Recent Development Table 92. GlaxoSmithKline Company Information Table 93. GlaxoSmithKline Business Overview Table 94. GlaxoSmithKline Antiemetics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. GlaxoSmithKline Antiemetics Product Portfolio Table 96. GlaxoSmithKline Recent Development Table 97. Baxter Company Information Table 98. Baxter Business Overview Table 99. Baxter Antiemetics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Baxter Antiemetics Product Portfolio Table 101. Baxter Recent Development Table 102. Sanofi Aventis Company Information Table 103. Sanofi Aventis Business Overview Table 104. Sanofi Aventis Antiemetics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Sanofi Aventis Antiemetics Product Portfolio Table 106. Sanofi Aventis Recent Development Table 107. Bristol Myers Squibb Company Information Table 108. Bristol Myers Squibb Business Overview Table 109. Bristol Myers Squibb Antiemetics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Bristol Myers Squibb Antiemetics Product Portfolio Table 111. Bristol Myers Squibb Recent Development Table 112. Astellas Company Information Table 113. Astellas Business Overview Table 114. Astellas Antiemetics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Astellas Antiemetics Product Portfolio Table 116. Astellas Recent Development Table 117. Key Raw Materials Table 118. Raw Materials Key Suppliers Table 119. Antiemetics Distributors List Table 120. Antiemetics Customers List Table 121. Research Programs/Design for This Report Table 122. Authors List of This Report Table 123. Secondary Sources Table 124. Primary Sources List of Figures Figure 1. Antiemetics Product Image Figure 2. Global Antiemetics Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antiemetics Sales Value (2021-2032) & (US$ Million) Figure 4. Global Antiemetics Sales (2021-2032) & (K Units) Figure 5. Global Antiemetics Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Antiemetics Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Steroids Image Figure 10. Antihistamines (H1 histamine receptor antagonists) Image Figure 11. Anticholinergics Image Figure 12. Dopamine antagonists Image Figure 13. Cannabinoids Image Figure 14. Benzodiazepines Image Figure 15. NK1 receptor antagonist Image Figure 16. 5-HT3 receptor antagonists Image Figure 17. Others Image Figure 18. Global Antiemetics Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Antiemetics Sales Volume Share 2021 VS 2025 VS 2032 Figure 20. Global Antiemetics Sales Volume Share by Type (2021-2032) Figure 21. Global Antiemetics Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Antiemetics Sales Value Share 2021 VS 2025 VS 2032 Figure 23. Global Antiemetics Sales Value Share by Type (2021-2032) Figure 24. Retail Pharmacy Image Figure 25. Online Pharmacy Image Figure 26. Hospital Pharmacy Image Figure 27. Others Image Figure 28. Global Antiemetics Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 29. Global Antiemetics Sales Volume Share 2021 VS 2025 VS 2032 Figure 30. Global Antiemetics Sales Volume Share by Application (2021-2032) Figure 31. Global Antiemetics Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 32. Global Antiemetics Sales Value Share 2021 VS 2025 VS 2032 Figure 33. Global Antiemetics Sales Value Share by Application (2021-2032) Figure 34. Global Antiemetics Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 35. Global Antiemetics Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 36. Global Antiemetics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 37. Global Antiemetics Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 38. North America Antiemetics Sales Value (2021-2032) & (US$ Million) Figure 39. North America Antiemetics Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Europe Antiemetics Sales Value (2021-2032) & (US$ Million) Figure 41. Europe Antiemetics Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Asia-Pacific Antiemetics Sales Value (2021-2032) & (US$ Million) Figure 43. Asia-Pacific Antiemetics Sales Value Share by Country (%), 2025 VS 2032 Figure 44. South America Antiemetics Sales Value (2021-2032) & (US$ Million) Figure 45. South America Antiemetics Sales Value Share by Country (%), 2025 VS 2032 Figure 46. Middle East & Africa Antiemetics Sales Value (2021-2032) & (US$ Million) Figure 47. Middle East & Africa Antiemetics Sales Value Share by Country (%), 2025 VS 2032 Figure 48. USA Antiemetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. USA Antiemetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. USA Antiemetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Canada Antiemetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Canada Antiemetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Canada Antiemetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Mexico Antiemetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Mexico Antiemetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Mexico Antiemetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Germany Antiemetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Germany Antiemetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Germany Antiemetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. France Antiemetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. France Antiemetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. France Antiemetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. U.K. Antiemetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. U.K. Antiemetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. U.K. Antiemetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Italy Antiemetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Italy Antiemetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Italy Antiemetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Spain Antiemetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Spain Antiemetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Spain Antiemetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Russia Antiemetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Russia Antiemetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Russia Antiemetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Netherlands Antiemetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Netherlands Antiemetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Netherlands Antiemetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Nordic Countries Antiemetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Nordic Countries Antiemetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Nordic Countries Antiemetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. China Antiemetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. China Antiemetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. China Antiemetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Japan Antiemetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Japan Antiemetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Japan Antiemetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. South Korea Antiemetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. South Korea Antiemetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. South Korea Antiemetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. India Antiemetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. India Antiemetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. India Antiemetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Australia Antiemetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Australia Antiemetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Australia Antiemetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Southeast Asia Antiemetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Southeast Asia Antiemetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Southeast Asia Antiemetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Brazil Antiemetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Brazil Antiemetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Brazil Antiemetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Argentina Antiemetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Argentina Antiemetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Argentina Antiemetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Chile Antiemetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Chile Antiemetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Chile Antiemetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Colombia Antiemetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Colombia Antiemetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Colombia Antiemetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Peru Antiemetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Peru Antiemetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Peru Antiemetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Saudi Arabia Antiemetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Saudi Arabia Antiemetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Saudi Arabia Antiemetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Israel Antiemetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Israel Arabia Antiemetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Israel Arabia Antiemetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. UAE Antiemetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. UAE Antiemetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. UAE Antiemetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Turkey Antiemetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Turkey Antiemetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Turkey Antiemetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Iran Antiemetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 127. Iran Antiemetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 128. Iran Antiemetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 129. Egypt Antiemetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 130. Egypt Antiemetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 131. Egypt Antiemetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 132. Antiemetics Value Chain Figure 133. Manufacturing Cost Structure Figure 134. Antiemetics Sales Mode & Process Figure 135. Direct Comparison with Distribution Share Figure 136. Distributors Profiles Figure 137. Years Considered Figure 138. Research Process Figure 139. Key Executives Interviewed

Scope & coverage.

Types
  • Steroids
  • Antihistamines (H1 histamine receptor antagonists)
  • Anticholinergics
  • Dopamine antagonists
  • Cannabinoids
  • Benzodiazepines
  • NK1 receptor antagonist
  • 5-HT3 receptor antagonists
  • Others
Applications
  • Retail Pharmacy
  • Online Pharmacy
  • Hospital Pharmacy
  • Others
Companies covered
  • Johnson & Johnson
  • Merck
  • Eli Lilly
  • Pfizer
  • GlaxoSmithKline
  • Baxter
  • Sanofi Aventis
  • Bristol Myers Squibb
  • Astellas

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Antiemetics Sales Value (2021-2032)
  4. 1.2.2 Global Antiemetics Sales Volume (2021-2032)
  5. 1.2.3 Global Antiemetics Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Antiemetics Market Dynamics
  1. 2.1 Antiemetics Industry Trends
  2. 2.2 Antiemetics Industry Drivers
  3. 2.3 Antiemetics Industry Opportunities and Challenges
  4. 2.4 Antiemetics Industry Restraints
3 Antiemetics Market by Company
  1. 3.1 Global Antiemetics Company Revenue Ranking in 2025
  2. 3.2 Global Antiemetics Revenue by Company (2021-2026)
  3. 3.3 Global Antiemetics Sales Volume by Company (2021-2026)
  4. 3.4 Global Antiemetics Average Price by Company (2021-2026)
  5. 3.5 Global Antiemetics Company Ranking (2024-2026)
  6. 3.6 Global Antiemetics Company Manufacturing Base and Headquarters
  7. 3.7 Global Antiemetics Company Product Type and Application
  8. 3.8 Global Antiemetics Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Antiemetics Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Antiemetics Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Antiemetics Market by Type
  1. 4.1 Antiemetics Type Introduction
  2. 4.1.1 Steroids
  3. 4.1.2 Antihistamines (H1 histamine receptor antagonists)
  4. 4.1.3 Anticholinergics
  5. 4.1.4 Dopamine antagonists
  6. 4.1.5 Cannabinoids
  7. 4.1.6 Benzodiazepines
  8. 4.1.7 NK1 receptor antagonist
  9. 4.1.8 5-HT3 receptor antagonists
  10. 4.1.9 Others
  11. 4.2 Global Antiemetics Sales Volume by Type
  12. 4.2.1 Global Antiemetics Sales Volume by Type (2021 VS 2025 VS 2032)
  13. 4.2.2 Global Antiemetics Sales Volume by Type (2021-2032)
  14. 4.2.3 Global Antiemetics Sales Volume Share by Type (2021-2032)
  15. 4.3 Global Antiemetics Sales Value by Type
  16. 4.3.1 Global Antiemetics Sales Value by Type (2021 VS 2025 VS 2032)
  17. 4.3.2 Global Antiemetics Sales Value by Type (2021-2032)
  18. 4.3.3 Global Antiemetics Sales Value Share by Type (2021-2032)
5 Antiemetics Market by Application
  1. 5.1 Antiemetics Application Introduction
  2. 5.1.1 Retail Pharmacy
  3. 5.1.2 Online Pharmacy
  4. 5.1.3 Hospital Pharmacy
  5. 5.1.4 Others
  6. 5.2 Global Antiemetics Sales Volume by Application
  7. 5.2.1 Global Antiemetics Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Antiemetics Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Antiemetics Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Antiemetics Sales Value by Application
  11. 5.3.1 Global Antiemetics Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Antiemetics Sales Value by Application (2021-2032)
  13. 5.3.3 Global Antiemetics Sales Value Share by Application (2021-2032)
6 Antiemetics Regional Sales and Value Analysis
  1. 6.1 Global Antiemetics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Antiemetics Sales by Region (2021-2032)
  3. 6.2.1 Global Antiemetics Sales by Region: 2021-2026
  4. 6.2.2 Global Antiemetics Sales by Region (2027-2032)
  5. 6.3 Global Antiemetics Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Antiemetics Sales Value by Region (2021-2032)
  7. 6.4.1 Global Antiemetics Sales Value by Region: 2021-2026
  8. 6.4.2 Global Antiemetics Sales Value by Region (2027-2032)
  9. 6.5 Global Antiemetics Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Antiemetics Sales Value (2021-2032)
  12. 6.6.2 North America Antiemetics Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Antiemetics Sales Value (2021-2032)
  15. 6.7.2 Europe Antiemetics Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Antiemetics Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Antiemetics Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Antiemetics Sales Value (2021-2032)
  21. 6.9.2 South America Antiemetics Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Antiemetics Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Antiemetics Sales Value Share by Country, 2025 VS 2032
7 Antiemetics Country-level Sales and Value Analysis
  1. 7.1 Global Antiemetics Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Antiemetics Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Antiemetics Sales by Country (2021-2032)
  4. 7.3.1 Global Antiemetics Sales by Country (2021-2026)
  5. 7.3.2 Global Antiemetics Sales by Country (2027-2032)
  6. 7.4 Global Antiemetics Sales Value by Country (2021-2032)
  7. 7.4.1 Global Antiemetics Sales Value by Country (2021-2026)
  8. 7.4.2 Global Antiemetics Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Antiemetics Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Antiemetics Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Antiemetics Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Antiemetics Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Antiemetics Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Antiemetics Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Antiemetics Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Antiemetics Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Antiemetics Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Antiemetics Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Antiemetics Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Antiemetics Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Antiemetics Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Antiemetics Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Antiemetics Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Antiemetics Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Antiemetics Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Antiemetics Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Antiemetics Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Antiemetics Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Antiemetics Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Antiemetics Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Antiemetics Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Antiemetics Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Antiemetics Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Antiemetics Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Antiemetics Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Antiemetics Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Antiemetics Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Antiemetics Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Antiemetics Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Antiemetics Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Antiemetics Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Antiemetics Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Antiemetics Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Antiemetics Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Antiemetics Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Antiemetics Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Antiemetics Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Antiemetics Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Antiemetics Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Antiemetics Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Antiemetics Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Antiemetics Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Antiemetics Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Antiemetics Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Antiemetics Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Antiemetics Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Antiemetics Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Antiemetics Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Antiemetics Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Antiemetics Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Antiemetics Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Antiemetics Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Antiemetics Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Antiemetics Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Antiemetics Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Antiemetics Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Antiemetics Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Antiemetics Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Antiemetics Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Antiemetics Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Antiemetics Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Antiemetics Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Antiemetics Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Antiemetics Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Antiemetics Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Antiemetics Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Antiemetics Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Antiemetics Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Antiemetics Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Antiemetics Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Antiemetics Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Antiemetics Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Antiemetics Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Antiemetics Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Antiemetics Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Antiemetics Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Antiemetics Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Antiemetics Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Antiemetics Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Antiemetics Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Antiemetics Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Antiemetics Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Johnson & Johnson
  2. 8.1.1 Johnson & Johnson Company Information
  3. 8.1.2 Johnson & Johnson Business Overview
  4. 8.1.3 Johnson & Johnson Antiemetics Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Johnson & Johnson Antiemetics Product Portfolio
  6. 8.1.5 Johnson & Johnson Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck Antiemetics Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Merck Antiemetics Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 Eli Lilly
  14. 8.3.1 Eli Lilly Company Information
  15. 8.3.2 Eli Lilly Business Overview
  16. 8.3.3 Eli Lilly Antiemetics Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Eli Lilly Antiemetics Product Portfolio
  18. 8.3.5 Eli Lilly Recent Developments
  19. 8.4 Pfizer
  20. 8.4.1 Pfizer Company Information
  21. 8.4.2 Pfizer Business Overview
  22. 8.4.3 Pfizer Antiemetics Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Antiemetics Product Portfolio
  24. 8.4.5 Pfizer Recent Developments
  25. 8.5 GlaxoSmithKline
  26. 8.5.1 GlaxoSmithKline Company Information
  27. 8.5.2 GlaxoSmithKline Business Overview
  28. 8.5.3 GlaxoSmithKline Antiemetics Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 GlaxoSmithKline Antiemetics Product Portfolio
  30. 8.5.5 GlaxoSmithKline Recent Developments
  31. 8.6 Baxter
  32. 8.6.1 Baxter Company Information
  33. 8.6.2 Baxter Business Overview
  34. 8.6.3 Baxter Antiemetics Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Baxter Antiemetics Product Portfolio
  36. 8.6.5 Baxter Recent Developments
  37. 8.7 Sanofi Aventis
  38. 8.7.1 Sanofi Aventis Company Information
  39. 8.7.2 Sanofi Aventis Business Overview
  40. 8.7.3 Sanofi Aventis Antiemetics Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Sanofi Aventis Antiemetics Product Portfolio
  42. 8.7.5 Sanofi Aventis Recent Developments
  43. 8.8 Bristol Myers Squibb
  44. 8.8.1 Bristol Myers Squibb Company Information
  45. 8.8.2 Bristol Myers Squibb Business Overview
  46. 8.8.3 Bristol Myers Squibb Antiemetics Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Bristol Myers Squibb Antiemetics Product Portfolio
  48. 8.8.5 Bristol Myers Squibb Recent Developments
  49. 8.9 Astellas
  50. 8.9.1 Astellas Company Information
  51. 8.9.2 Astellas Business Overview
  52. 8.9.3 Astellas Antiemetics Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Astellas Antiemetics Product Portfolio
  54. 8.9.5 Astellas Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Antiemetics Value Chain Analysis
  2. 9.1.1 Antiemetics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Antiemetics Sales Mode & Process
  6. 9.2 Antiemetics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Antiemetics Distributors
  9. 9.2.3 Antiemetics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst